Evidence map›Paper›PMID 19638650›Full record

ArticleBMJ (Clinical research ed.)2009

Performance evaluation of a new rapid urine test for chlamydia in men: prospective cohort study.

Elpidio-Cesar Nadala, Beng T Goh, Jose-Paolo Magbanua, Penelope Barber, Alison Swain, Sarah Alexander, Vivian Laitila, Claude-Edouard Michel, Lourdes Mahilum-Tapay, Ines Ushiro-Lumb and 2 more

Open access · hybridAbstract readEvaluation StudyMulticenter Study
In one paragraph

Article in BMJ (Clinical research ed.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Elpidio-Cesar NadalaDiagnostics for the Real World (Europe), Cambridge Science Park, Cambridge CB4 0WG.
Beng T Goh
Jose-Paolo Magbanua
Penelope Barber
Alison Swain
Sarah Alexander
Vivian Laitila
Claude-Edouard Michel
Lourdes Mahilum-Tapay
Ines Ushiro-Lumb
Catherine Ison
Helen H Lee
NHS Blood and Transplant · GBBarts Health NHS Trust · GBHealth Protection Agency · MVVitenparken · NODiagnostics for the Real World (United States) · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

objectiveTo evaluate the performance of a rapid test for chlamydia with first void male urine samples as a potential tool for diagnosis and screening of chlamydial infection in men.

designEvaluation of test performance in prospective cohort study. Settings A young people's sexual health centre (site 1) and a genitourinary medicine clinic (site 2) in the United Kingdom.

participants1211 men aged 16-73 attending either of the two sites.

main outcome measuresSensitivity, specificity, positive predictive value, and negative predictive value of the Chlamydia Rapid Test versus polymerase chain reaction assay. Relation between the visual signal of the Chlamydia Rapid Test and organism load.

resultsDetection rates for Chlamydia trachomatis infection with polymerase chain reaction were 4.4% (20/454) at site 1 and 11.9% (90/757) at site 2. Compared with polymerase chain reaction assay, the resolved sensitivity, specificity, positive predictive value, and negative predictive value of the Chlamydia Rapid Test was 82.6% (90/109), 98.5% (1085/1102), 84.1% (90/107), and 98.3% (1085/1104), respectively. The organism load in first void urine samples that were positive for chlamydia ranged from 7.28x10(2) to 6.93x10(6) plasmids/ml and correlated significantly with the visual signal of the Chlamydia Rapid Test (r=0.7897, P<0.001).

conclusionsThe performance of the new Chlamydia Rapid Test with first void male urine samples indicates that it would be an effective diagnostic tool for chlamydial infection in men. The availability of test results within an hour allows for immediate treatment and contact tracing, potentially reducing the risks of persistent infection and onward transmission. The test could also provide a simple and reliable alternative to nucleic acid amplification assays for testing of male urine in chlamydial screening programmes in high prevalence settings.

Indexed as

AdolescentAdultAgedChlamydia InfectionsHumansMaleMiddle AgedPatient SatisfactionPolymerase Chain ReactionProspective StudiesReagent StripsSensitivity and SpecificityUrinalysisYoung AdultReagent Strips

Identifiers

PMID19638650
PMCPMC2718085
OpenAlexW1990524112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.